| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total revenues | $243K-87.8% | $2.0M+61.5% | $1.2M+115.6% | $570K-89.1% | $5.2M |
| Total costs of goods sold and services | $23.0M+9.3% | $21.0M+10.4% | $19.0M+9.9% | $17.3M+18.0% | $14.7M |
| Gross profit | $65.0M-21.8% | $83.1M+12.0% | $74.2M+63.6% | $45.4M-26.5% | $61.7M |
| Research and development | $35.9M+15.6% | $31.1M+19.3% | $26.1M-2.8% | $26.8M-4.2% | $28.0M |
| Selling, general and administrative | $138.0M+35.8% | $101.6M+14.0% | $89.1M-3.0% | $91.9M-0.5% | $92.3M |
| Other lease costs | $844K-72.1% | $3.0M-18.6% | $3.7M+163.1% | $1.4M | — |
| Impairment and restructuring | $15.7M | $0-100.0% | $1.3M-95.5% | $29.6M | $0 |
| Total operating expenses | $190.5M+40.4% | $135.7M+12.9% | $120.2M-19.7% | $149.6M+24.4% | $120.3M |
| Loss from operations | -$125.5M-138.6% | -$52.6M-14.4% | -$46.0M+55.9% | -$104.3M-78.0% | -$58.6M |
| Interest income | $8.6M-41.5% | $14.7M-7.5% | $15.8M+208.7% | $5.1M+1373.2% | -$403K |
| Change in fair value of contingent liabilities | -$4.5M | $0 | $0 | — | — |
| Other income (expense), net | $157K+215.4% | -$136K-105.4% | $2.5M+1008.7% | -$277K-121.9% | $1.3M |
| Loss before income taxes | -$112.3M-194.7% | -$38.1M-37.9% | -$27.6M+72.2% | -$99.4M-72.2% | -$57.7M |
| Income tax benefit (expense) | $5.1M+1280.0% | -$434K+39.6% | -$719K-338.4% | -$164K-555.6% | $36K |
| Net loss | -$107.2M-178.1% | -$38.5M-35.9% | -$28.4M+71.5% | -$99.6M-72.6% | -$57.7M |
| Net loss per common share, basic (in dollars per share) | -$2.51-151.0% | -$1.00-33.3% | -$0.75+72.1% | -$2.69-68.1% | -$1.60 |
| Net loss per share, diluted (in dollars per share) | -$2.51-151.0% | -$1.00-33.3% | -$0.75+72.1% | -$2.69-68.1% | -$1.60 |
| Weighted-average common shares outstanding, basic (in shares) | 42.6M+11.1% | 38.4M+2.1% | 37.6M+1.6% | 37.0M+2.8% | 36.0M |
| Weighted-average common shares outstanding, diluted (in shares) | 42.6M+11.1% | 38.4M+2.1% | 37.6M+1.6% | 37.0M+2.8% | 36.0M |
| Product revenue | |||||
| Service and Other Revenue | |||||
| Collaboration and license revenue | |||||
| Grant revenue | |||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.